AFT appoints McPherson’s as Singapore distributor

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com





5 November 2021
AFT appoints McPherson’s as Singapore distributor
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) has signed an exclusive distribution
agreement with ASX-listed McPherson’s Limited (ASX: MCP) to drive growth of its over
the counter (OTC) products in Singapore.
The move is aimed at maximising the potential for AFT’s medicines in Singapore, where
the OTC market is worth approximately $US600 million and is forecast to grow at
around 5.45% to reach $US800 million by 2026*. It is also part of AFT’s broader strategy
to grow its presence in Asia.
McPherson’s will distribute and market the tablet form of AFT’s patented Maxigesic
pain relief medicine, launched in Singapore in 2018, AFT’s premium Liposomal
Nutritional Supplements as well as a number of other newly registered
pharmaceuticals.
The agreement seeks to leverage McPherson’s experienced sales and marketing
teams in Singapore and will ensure channel strategies and product and
merchandising activations are tailored to the local market.
AFT Pharmaceuticals Chief Executive Dr Hartley Atkinson said: “This partnership affirms
AFT’s commitment to building new categories and distribution in existing Asian markets
and further reaching out into the region.
“We are very pleased with the progress we have made in Singapore, but this
agreement with McPherson’s, a specialist OTC distributor, ensures we are aligned with
the right partners to ensure success in the future”
McPherson’s Chief Executive Officer, Grant Peck said “We believe our established
distribution channels and strong sales team in Singapore are a great fit for AFT and we
are excited for what this partnership will achieve together. AFT’s OTC product brands
have great synergies with McPherson’s focus in the health category and we are
committed to market growth.”
For and on behalf of AFT Pharmaceuticals Limited by Malcolm Tubby, Chief Financial
Officer.
For more information:
Investors Media
Dr Hartley Atkinson Richard Inder
Managing Director The Project
AFT Pharmaceuticals Tel: +64 21 645 643
Tel: +64 9488 0232

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com




*https://www.marketdataforecast.com/market-reports/singapore-over-the-counter-drugs-market

About AFT Pharmaceuticals
AFT is a growing multinational pharmaceutical company that develops, markets and
distributes a broad portfolio of pharmaceutical products across a wide range of
therapeutic categories which are distributed across all major pharmaceutical
distribution channels: over the counter (OTC), prescription and hospital. Our product
portfolio comprises both proprietary and in-licensed products, and includes patented,
branded and generic drugs. Our business model is to develop and in-license products
for sale by our own dedicated sales teams in our home markets of Australia and New
Zealand and in certain Southeast Asian markets, and to out-license our products to
local licensees and distributors to over 125 countries around the world. For more
information about the company, visit our website www.aftpharm.com
.
About McPherson’s Limited
McPherson’s, established in 1860, is a leading supplier of Health, Wellness and Beauty
products with operations in Australia, New Zealand and Asia. McPherson’s markets
and distributes beauty care, hair care, skin care, vitamins, supplements, and personal
care items such as facial wipes, cotton pads and foot comfort products, as well as a
range of kitchen essentials such as baking paper, cling wrap and aluminium foil.
McPherson’s revenue is primarily derived from its diversified portfolio of owned,
market-leading brands, including Dr. LeWinn’s, A’kin, Manicare, Lady Jayne,
Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead and Maseur.
McPherson’s also manages several brands for agency partners.
For further information on McPherson’s business and its strategy and to view the most
recent corporation video please refer to the company’s website
http://www.mcphersons.com.au